Primiano, Guido Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 3.091
AS - Asia 2.376
EU - Europa 2.011
SA - Sud America 569
AF - Africa 74
OC - Oceania 16
AN - Antartide 1
Totale 8.138
Nazione #
US - Stati Uniti d'America 2.975
SG - Singapore 1.029
IT - Italia 535
CN - Cina 521
BR - Brasile 472
DE - Germania 404
SE - Svezia 293
VN - Vietnam 280
FR - Francia 192
IE - Irlanda 100
IN - India 96
FI - Finlandia 94
GB - Regno Unito 85
BD - Bangladesh 79
UA - Ucraina 69
ID - Indonesia 68
HK - Hong Kong 64
CA - Canada 59
JP - Giappone 59
RU - Federazione Russa 53
MX - Messico 33
NL - Olanda 32
PL - Polonia 31
AR - Argentina 30
ES - Italia 27
KR - Corea 26
ZA - Sudafrica 24
IQ - Iraq 20
AT - Austria 19
IR - Iran 19
TR - Turchia 18
EC - Ecuador 16
BE - Belgio 15
AU - Australia 12
LT - Lituania 12
CI - Costa d'Avorio 11
CO - Colombia 11
CZ - Repubblica Ceca 11
MA - Marocco 11
PH - Filippine 11
KE - Kenya 10
VE - Venezuela 10
CL - Cile 9
PK - Pakistan 9
CH - Svizzera 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
JO - Giordania 7
PE - Perù 7
SA - Arabia Saudita 7
TH - Thailandia 7
UZ - Uzbekistan 7
PY - Paraguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
KZ - Kazakistan 5
UY - Uruguay 5
DK - Danimarca 4
GR - Grecia 4
GT - Guatemala 4
LK - Sri Lanka 4
NZ - Nuova Zelanda 4
RS - Serbia 4
TT - Trinidad e Tobago 4
BO - Bolivia 3
CR - Costa Rica 3
ET - Etiopia 3
KG - Kirghizistan 3
LB - Libano 3
LV - Lettonia 3
MY - Malesia 3
NP - Nepal 3
TN - Tunisia 3
TW - Taiwan 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
DO - Repubblica Dominicana 2
EG - Egitto 2
MD - Moldavia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SI - Slovenia 2
SV - El Salvador 2
AQ - Antartide 1
CG - Congo 1
CY - Cipro 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LY - Libia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
Totale 8.132
Città #
Singapore 541
Chandler 386
San Jose 348
Ashburn 338
Munich 139
Rome 139
New York 133
Beijing 128
Dublin 95
Ho Chi Minh City 91
St Louis 89
Los Angeles 79
Hanoi 74
Hefei 69
Chicago 64
Lauterbourg 62
San Mateo 60
Jakarta 59
Hong Kong 56
Helsinki 51
Milan 51
Tokyo 48
Dallas 44
São Paulo 42
Frankfurt am Main 41
Ann Arbor 37
Boston 37
Jacksonville 34
The Dalles 34
Wilmington 34
Princeton 33
Council Bluffs 32
Nanjing 32
Buffalo 31
Boardman 30
Houston 28
Moscow 28
Cattolica 25
Redmond 25
Kent 23
Orem 23
Seoul 23
Marseille 22
Bremen 21
Rio de Janeiro 21
Santa Clara 21
Norwalk 19
Warsaw 18
Guangzhou 17
Seattle 17
Toronto 17
Woodbridge 17
Atlanta 16
Johannesburg 16
Nuremberg 16
Trieste 16
Brussels 15
Haiphong 15
Montreal 15
Pune 15
Redwood City 15
Brooklyn 14
Da Nang 14
Dearborn 14
Fairfield 14
Lappeenranta 14
London 13
Nanchang 13
North Bergen 13
Paris 13
Stockholm 13
Amsterdam 12
Mexico City 12
Nürnberg 12
Shanghai 12
Turku 12
Abidjan 11
Busto Arsizio 11
Lawrence 11
Düsseldorf 10
Mumbai 10
Naples 10
Vienna 10
Augusta 9
Baghdad 9
Bari 9
Brasília 9
Detroit 9
Palermo 9
Phoenix 9
Andover 8
Belo Horizonte 8
Campinas 8
Chennai 8
Hangzhou 8
Sydney 8
Washington 8
Zurich 8
Amman 7
Bexley 7
Totale 4.474
Nome #
Hospital admissions from the emergency department of adult patients affected by myopathies 260
Sporadic late-onset nemaline myopathy: clinical, pathology and imaging findings in a single center cohort 210
Hearing Impairment and Neuroimaging Results in Mitochondrial Diseases 203
Assessment of neurological manifestations in hospitalized patients with COVID-19 198
Acute myopathic quadriplegia in COVID-19 patients in the intensive care unit 193
"Myo-cardiomyopathy" is commonly associated with the A8344G "MERRF" mutation 185
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 176
Copper deficiency myelopathy: A report of two cases 167
Mitochondrial neuropathy: considerations on pathogenesis 166
Peripheral neuropathy is a common manifestation of mitochondrial diseases: a single-centre experience 155
Clinical utility of genetic testing in the early diagnosis of Danon disease mimicking hypertrophic cardiomyopathy: A case report 146
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 145
Resolving Phenotypic Variability in Mitochondrial Diseases: Preliminary Findings of a Proteomic Approach 145
An Italian Neurology Outpatient Clinic Facing SARS-CoV-2 Pandemic: Data From 2,167 Patients 143
Resolution of muscle inflammation after tumor removal in a woman with paraneoplastic dermatomyositis 137
Biallelic SQSTM1 mutations in early-onset, variably progressive neurodegeneration 133
Acute refractory intestinal pseudo-obstruction in MELAS: efficacy of prucalopride 132
Clinical features and outcome of patients with autoimmune cerebellar ataxia evaluated with the Scale for the Assessment and Rating of Ataxia 131
Intestinal pseudo-obstruction in mitochondrial diseases 130
A coordinated multiorgan metabolic response contributes to human mitochondrial myopathy 126
Expanding the spectrum of congenital myopathies: prenatal onset with extreme hyperextension of the neck 126
A Metabolic Signature of Hereditary Transthyretin Amyloidosis: A Pilot Study 124
Macular impairment in mitochondrial diseases: a potential biomarker of disease severity 123
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX) 121
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 121
Spinal cord demyelination in children: A diagnostic challenge in neuropaediatrics for a good outcome 120
Early cardiac mechanics abnormalities in patients with mitochondrial diseases 117
Oculopharyngeal muscular dystrophy: Clinical and neurophysiological features 117
Frequency of Cerebrovascular Abnormalities in Patients with Late-Onset Pompe Disease: Our Experience 117
Midbrain panda sign in a patient with Wilson's disease 113
Muscle MRI as a useful biomarker in hereditary transthyretin amyloidosis: A pilot study 113
Clinical, Histopathologic, and Genetic Features of Patients With Myofibrillary and Distal Myopathies 111
Small fibre neuropathy in mitochondrial diseases explored with sudoscan 109
Neurofilament light chain as a disease severity biomarker in ATTRv: data from a single-centre experience 109
Osteoma of the internal auditory canal 103
Assessment of neurological manifestations in hospitalized patients with COVID-19 102
Novel TOP3A Variant Associated With Mitochondrial Disease: Expanding the Clinical Spectrum of Topoisomerase III Alpha-Related Diseases 102
Myoclonus in mitochondrial disorders 102
Fourier-transform infrared spectroscopy of skeletal muscle tissue: Expanding biomarkers in primary mitochondrial myopathies 102
Spinal cord involvement in adult mitochondrial diseases: A cohort study 101
Emerging multisystem biomarkers in hereditary transthyretin amyloidosis: a pilot study 100
Recurrent kidney stones in a family with a mitochondrial disorder due to the m.3243A>G mutation 100
Do rare genetic conditions exhibit a specific phonotype? A comprehensive description of the vocal traits associated with Crisponi/Cold-Induced Sweating Syndrome type 1. 99
Correction to: Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review 97
Inflammatory profile in mitochondrial diseases: A cohort study 96
Acute refractory intestinal pseudo-obstruction in melas: Efficacy of prucalopride 95
Serum Biomarkers in Transthyretin Amyloidosis: An Overview of Neurofilaments, Cardiac, Renal, and Gastrointestinal Involvement 94
Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide 93
Migraine in mitochondrial disorders: Prevalence and characteristics 93
Sleep-Disordered Breathing in Adult Patients With Mitochondrial Diseases: A Cohort Study 93
Limb-Girdle Muscular Dystrophies (LGMDs): The Clinical Application of NGS Analysis, a Family Case Report 91
A voxel-based lesion symptom mapping analysis of chronic pain in multiple sclerosis 91
Elevated serum concentrations of GFAP in hereditary transthyretin amyloidosis since pre-symptomatic stages 90
Defining the clinical-genetic and neuroradiological features in SPG54: description of eight additional cases and nine novel DDHD2 variants 87
Systematic assessment and characterization of chronic pain in multiple sclerosis patients 86
Drug-resistant epilepsy in MELAS: safety and potential efficacy of lacosamide 84
Progressive axonal polyneuropathy in a mitochondrial disorder: an uncommon association with familial amyloid neuropathy 83
Prognostic indicators and outcomes of hospitalised COVID-19 patients with neurological disease: An individual patient data meta-analysis 79
Inflammatory profile in mitochondrial diseases: A cohort study 78
Preventive migraine treatment in mitochondrial diseases: a case report of erenumab efficacy and literature review 78
Sudoscan in ATTRv Amyloidosis: A Potential Marker of Disease Progression? 78
Epilepsy management in mitochondrial diseases 78
Muscle pain in mitochondrial diseases: a picture from the Italian network 77
Teaching Video NeuroImages: Palatal tremor associated with SPG7 variants 77
Mitochondrial Biomarkers in the Omics Era: A Clinical-Pathophysiological Perspective 76
Mitochondrial epilepsy: a cross-sectional nationwide Italian survey 76
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial Patients 71
Clinical, neurophysiological and serological clues for the diagnosis of neuromyotonia and distinction from cramp-fasciculation syndrome 68
Reply to “Work-up for mitochondrial small fiber neuropathy requires application of skin biopsies” 66
Vitamin D in Neurological Diseases 64
Ophthalmological signs and sensorimotor evaluation in mitochondrial chronic progressive external ophthalmoplegia: a multidisciplinary prospective study 61
Revisiting mitochondrial ocular myopathies: a study from the Italian Network 61
A severe linezolid-induced rhabdomyolysis and lactic acidosis in Leigh syndrome 45
Cross-cultural adaptation of the Italian version of the "Child and Youth Mental Health Instrument for Developmental Disabilities" (I-ChYMH-DD) 16
Cross-cultural adaptation of the Italian version of the “Child and Youth Mental Health Instrument for Developmental Disabilities” (I-ChYMH-DD) 7
Serum Galectin-3 as a biomarker in acute inflammatory polyradiculoneuropathies: a cohort study. 6
Urinary Multi-Omics Profiling Reveals Systemic Molecular Alterations in Progressive External Ophthalmoplegia 4
Serum peripherin as a disease biomarker in hereditary transthyretin amyloidosis: a multicenter cohort study 4
Totale 8.276
Categoria #
all - tutte 34.882
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022387 36 12 8 20 20 12 5 68 15 22 79 90
2022/2023974 115 139 57 158 57 139 38 71 122 44 27 7
2023/2024681 17 138 20 77 23 112 39 35 6 42 98 74
2024/20251.488 25 29 108 72 79 71 98 81 183 137 327 278
2025/20263.777 510 142 250 540 504 183 576 158 221 357 176 160
2026/2027111 111 0 0 0 0 0 0 0 0 0 0 0
Totale 8.276